Previous reports show that GREM128 has a proangiogenic function by directly binding to vascular endothelial growth factor receptor 229 and may increase angiogenesis, which is associated with poorer prognosis.30 The expression of CRISP3 was associated clinical outcome in prostate cancer.31 This evidence concerns the gene CRISP3 and prostate carcinoma.